Maistering B.V & Mesterbakeren AS Sign a 5-year Digital Transformation Deal
28.1.2021 10:00:00 EET | Business Wire | Press release
Maistering, a global provider of an AI-infused business orchestration platform, today announced a strategic 5-year digital partnership with Mesterbakeren™.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210127006094/en/
Mesterbakeren™, headquartered in Oslo, Norway are the leading bakers offering the best in bread and bakery products to over 600 stores all over Norway.
As part of this engagement, Maistering, through its artificial intelligence platform, Master Collections, will deliver a complete 360° business view through enhanced collaboration with Mesterbakeren’s factories, partners and retail stores. The new platform augments leadership and teams with digital grip through AI-infused engines for insight, collaboration, creation, execution and governance.
Master Collections by Maistering is curated to enrich and speed up transformation initiatives. It allows leaders to plot and execute magical business journeys on the fly to improve, transform and innovate. The platform supports a fully virtual organization in a post-Covid world.
“Master Collections is a unique platform that helps enterprises orchestrate Journeys to reinvent themselves and shape value for customers, staff and partners. It will put AI-rich services and deep content at the fingertips of the Mesterbakeren™ team,” said Maistering CEO, John Brahim.
“After a two-month pilot with Maistering, we were convinced that Master Collections is the right platform for our digital transformation in our entire business from bakeries to customers. With Master Collections we radically shortened the introduction of a new product quality process. Our mission to be the leading bakery in Norway, inspiring, simple and best in taste, will be reinforced by going digital with Maistering,” added Tor Søreide Sivertsen, CEO of Mesterbakeren AS.
About Maistering B.V
Maistering is a global provider of an Enterprise SaaS business orchestration platform. An innovator that nurtures the innocence and energy of a millennial start-up with the deep, proven experience of business insights veterans. Headquartered in The Netherlands and supported by the uniquely designed CXO lab in Amsterdam, an AI hotspot, Maistering R&D sites are located in Bangalore (India), Rotterdam (Netherlands) and Valencia (Spain).
For additional information, please visit https://www.maistering.com/
About Mesterbakeren AS
Mesterbakeren™ delivers fresh baked goods to REMA 1000 in Norway. 20 bakeries supply retail stores all over the country with fresh bread, buns and rolls every day. The company targets to offer the best quality to Norwegian consumers, without costing more.
For additional information, please visit https://www.mesterbakeren.no/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210127006094/en/
Contact information
Maistering B.V
Vinutha Naik
Marketing Director
Vinutha.naik@maistering.com
Mesterbakeren AS
Steinar Bøe
IT Manager
steinar.boe@mesterbakeren.no
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 13:00:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission
KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 13:00:00 EEST | Press release
KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige
HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 12:15:00 EEST | Press release
HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612936893/en/ HUI (HUI:VSE) merges traditional and crypto finance: commences continuous trading in Vienna with leading market maker and announces impending token listing on major global exchange Emmanuelle Deba
Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 10:35:00 EEST | Press release
India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of its farming population. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202606151544
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 10:00:00 EEST | Press release
Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discovery teams to accelerate decision-making, streamline workflows, and advance programs more efficiently from hit identification through lead optimization. "Drug discovery increasingly requires seamless integration between chemistry and biology," said Michael Dabrowski, Chief Executive Officer of Pelago Bioscience. "By bringing RG Discovery
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom